Evolent Health (EVH) Interest Expenses (2014 - 2026)

Evolent Health's Interest Expenses history runs 13 years deep, the most recent figure standing at $44.0 million for Q1 2026.

• On a quarterly basis, Interest Expenses fell 11.67% year-over-year to $44.0 million in Q1 2026; TTM through Mar 2026 was $44.0 million, a 11.67% decrease from a year earlier, with the FY2025 full-year figure at $74.9 million, up 56.5% from the prior year.
• Interest Expenses advanced to $44.0 million in Q1 2026 per EVH's latest filing, from $19.0 million in the prior quarter.
• Across five years, Interest Expenses topped out at $60.6 million in Q3 2023 and bottomed at $6.4 million in Q4 2022.
• The 5-year median for Interest Expenses is $47.5 million (2025), against an average of $37.4 million.
• Across the five-year window, Interest Expenses surged 216.15% in 2023 and slumped 45.09% in 2024, its largest moves.
• Year by year, Interest Expenses stood at $6.4 million in 2022, then soared by 90.36% to $12.2 million in 2023, then slumped by 45.09% to $6.7 million in 2024, then soared by 182.89% to $19.0 million in 2025, then soared by 131.24% to $44.0 million in 2026.
• Per Business Quant, the three latest EVH Interest Expenses figures stand at $44.0 million (Q1 2026), $19.0 million (Q4 2025), and $47.5 million (Q3 2025).